Right Ventricular Dysfunction in Bone Marrow Transplantation: An Emerging Component of Cancer Therapy–Related Cardiotoxicity

Key Result

Right ventricular dysfunction is an emerging component of cancer therapy-related cardiotoxicity in patients undergoing bone marrow transplantation.

Key Points

• To investigate the role of right ventricular dysfunction in the context of cardiotoxicity related to bone marrow transplantation.
• Review of existing literature regarding cardiac health post-bone marrow transplantation.
• Analysis of mechanisms contributing to right ventricular dysfunction in cancer therapy.
• Emerging evidence suggests a significant link between bone marrow transplantation and right ventricular dysfunction.
• Cardiotoxicity rates may increase in patients undergoing cancer therapy, necessitating close cardiovascular monitoring.